SLC17A7
From Wikipedia, the free encyclopedia
|
Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | SLC17A7; BNPI; VGLUT1 | |||||||||||||
| External IDs | OMIM: 605208 HomoloGene: 69302 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 57030 | n/a | ||||||||||||
| Ensembl | ENSG00000104888 | n/a | ||||||||||||
| Refseq | NM_020309 (mRNA) NP_064705 (protein) |
n/a (mRNA) n/a (protein) |
||||||||||||
| Location | Chr 19: 54.62 - 54.64 Mb | n/a | ||||||||||||
| Pubmed search | [1] | n/a | ||||||||||||
Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, also known as SLC17A7, is a human gene.[1]
The protein encoded by this gene is a vesicle-bound, sodium-dependent phosphate transporter that is specifically expressed in the neuron-rich regions of the brain. It is preferentially associated with the membranes of synaptic vesicles and functions in glutamate transport. The protein shares 82% identity with the differentiation-associated Na-dependent inorganic phosphate cotransporter and they appear to form a distinct class within the Na+/Pi cotransporter family.[1]
[edit] See also
[edit] References
[edit] Further reading
- Ni B, Du Y, Wu X, et al. (1996). "Molecular cloning, expression, and chromosomal localization of a human brain-specific Na(+)-dependent inorganic phosphate cotransporter.". J. Neurochem. 66 (6): 2227-38. PMID 8632143.
- Aihara Y, Mashima H, Onda H, et al. (2000). "Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter.". J. Neurochem. 74 (6): 2622-5. PMID 10820226.
- Bellocchio EE, Reimer RJ, Fremeau RT, Edwards RH (2000). "Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter.". Science 289 (5481): 957-60. PMID 10938000.
- Takamori S, Rhee JS, Rosenmund C, Jahn R (2000). "Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons.". Nature 407 (6801): 189-94. doi:. PMID 11001057.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi:. PMID 14702039.
- Eastwood SL, Harrison PJ (2005). "Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.". Schizophrenia Research 73 (2-3): 159-72. doi:. PMID 15653259.
- Alonso-Nanclares L, De Felipe J (2005). "Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex.". Neuroscience 134 (1): 59-68. doi:. PMID 15961236.
- Vinatier J, Herzog E, Plamont MA, et al. (2006). "Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis.". J. Neurochem. 97 (4): 1111-25. doi:. PMID 16606361.
- Almqvist J, Huang Y, Laaksonen A, et al. (2007). "Docking and homology modeling explain inhibition of the human vesicular glutamate transporters.". Protein Sci. 16 (9): 1819-29. doi:. PMID 17660252.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.

